Role of the gp85/trans-sialidase superfamily of glycoproteins in the interaction of trypanosoma cruzi with host structures

Subcellular Biochemistry

Volumn 47, Issue , 2008, Pages 58-69

  Alves, Maria Júlia M ^a   Colli, Walter ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA; TRYPANOSOMA CRUZI;

GLYCOPROTEIN; PEPTIDE APTAMER; SIALIDASE; TRANS SIALIDASE; TRANS-SIALIDASE;

ANIMAL; BIOLOGICAL MODEL; CELL ADHESION; CHEMISTRY; COMBINATORIAL CHEMISTRY; GENETICS; HOST PARASITE INTERACTION; HUMAN; METABOLISM; PATHOGENICITY; PHYSIOLOGY; REVIEW; TRYPANOSOMA CRUZI;

ANIMALS; APTAMERS, PEPTIDE; CELL ADHESION; GLYCOPROTEINS; HOST-PARASITE INTERACTIONS; HUMANS; MODELS, BIOLOGICAL; NEURAMINIDASE; SELEX APTAMER TECHNIQUE; TRYPANOSOMA CRUZI;

EID: 46249112212     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78267-6_4     Document Type: Article

References (89)

1. Chagas C. Nova tripanosomiaze humana. Mem Inst Oswaldo Cruz 1909; I(II):159.
2. Hoare CA. The Trypanosomes of Mammals. Oxford: Blackwell Scientific Publications, 1972.
3. De Souza W. Basic cell biology of Trypanosoma cruzi. Curr Pharm Des 2002; 8(4):269-285.
4. Almeida-de-Faria M, FreymuUer E, Colli W et al. Trypanosoma cruzi: Characterization of an intracellular epimastigote-like form. Exp Parasitol 1999; 92(4):263-274.
5. Tyler KM, Engman DM. The life cycle of Trypanosoma cruzi revisited. Int J Parasitol 2001; 31(5-6):472-481.
6. Tonelli RR, Silber AM, Almeida-de-Faria M et al. L-proline is essential for the intracellular differentiation of Trypanosoma cruzi. Cell Microbiol 2004; 6(8):733-741.
7. WHO. Technical Report Series: WHO Publications, 2002.
8. WiUiams-Blangero S, VandeBerg JL, Blangero J et al. Genetic epidemiology of Trypanosoma cruzi infection and Chagas' disease. Front Biosci 2003; 8:e337-345.
9. Buscaglia CA, Di Noia JM. Trypanosoma cruzi clonal diversity and the epidemiology of Chagas' disease. Microbes Infect 2003; 5(5):4l9-427.
10. Macedo AM, Machado CR, Oliveira RP et al. Trypanosoma cruzi: Genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease. Mem Inst Oswaldo Cruz 2004; 99(1):1-12.
11. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001; 1:92-100.
12. Mortara RA, Andreoli WK, Taniwaki NN et al. Mammalian cell invasion and intracellular trafficking by Trypanosoma cruzi infective forms. An Acad Bras Cienc 2005; 77(1):77-94.
13. Lima MT, Lenzi HL, Gattass CR. Negative tissue parasitism in mice injected with a noninfective clone of Trypanosoma cruzi. Parasitol Res 1995; 81(1):6-12.
14. Lenzi HL, Oliveira DN, Lima MT et al. Trypanosoma cruzi: Paninfectivity of CL strain during murine acute infection. Exp Parasitol 1996; 84(1): 16-27.
15. Schenkman S, Mortara RA. HeLa cells extend and internalize pseudopodia during active invasion by Trypanosoma cruzi trypomastigotes. J Cell Sci 1992; 101(Pt 4):895-905.
16. Freitas JM, Lages-Silva E, Crema E et al. Real time PCR strategy for the identification of major linees of Trypanosoma cruzi directly in chronically infected human tissues. Int J Parasitol 2005; 35(4):411-417.
17. Taliaferro H, Pizzi T. Connective tissue reaction in normal and immunized mice to a reticulotropic strains of Trypanosoma cruzi. J Infect Dis 1955; 96:199-226.
18. Bice D, Zeledon R. Comparison of infectivity of strains of Trypanosoma cruzi (Chagas 1909). J Parasitol 1970; 56:663-670.
19. Melo RaB Z. Tissue tropism of different T. cruzi strains. J Parasitol 1978; 64:475-482.
20. Schoemaker J, Hoffman JR, Hoffman DC. Trypanosoma cruzi: Preference for brown adipose tissue in mice by theTulahuen strain. Exp Parasitol 1970; 27:403-407.
21. Buckner FS, Wilson AJ, Van Voorhis WC. Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase. Infect Immun 1999; 67(1):403-409.
22. Burleigh BA, Andrews NW. The mechanisms of Trypanosoma cruzi invasion of mammalian cells. Annu Rev Microbiol 1995; 49:175-200.
23. Burleigh BA, Woolsey AM. Cell signalUng and Trypanosoma cruzi invasion. Cell Microbiol 2002; 4(11):701-711.
24. Yoshida N. Molecular basis of mammalian cell invasion by Trypanosoma cruzi. Anais da Academia Brasileira de Ciencias 2005; 77(3): 1-25.
25. Barbosa HS, Meirelles MN. Evidence of participation of cytoskeleton of heart muscle cells during the invasion of Trypanosoma cruzi. Cell Struct Funct 1995; 20(4):275-284.
26. Mortara RA. Trypanosoma cruzi: Amastigotes and trypomastigotes interact with diflPerent structures on the surface of HeLa cells. Exp Parasitol 1991; 73(1): 1-14.
27. Ley V, Robbins ES, Nussenzweig V et al. The exit of Trypanosoma cruzi from the phagosome is inhibited by raising the pH of acidic compartments. J Exp Med 1990; 171(2):401-413.
28. Andrade LO, Andrews NW. The Trypanosoma cruzi-host-cell interplay: Location, invasion, retention. Nat Rev Microbiol 2005; 3(10):819-823.
29. Burleigh BA. Host cell signaling and Trypanosoma cruzi invasion: Do all roads lead to lysosomes? Sci STKE 2005; 2005(293):pe36.
30. Wilkowsky SE, Barbieri MA, Stahl PD et al. Regulation of Trypanosoma cruzi invasion of nonphagocytic cells by the endocytically active GTPases dynamin, Rab5, and Rab7. Biochem Biophys Res Commun 2002; 291(3):516-521.
31. Andrade LO, Andrews NW. Lysosomal fusion is essential for the retention of Trypanosoma cruzi inside host cells. J Exp Med 2004; 200(9):1135-1143.
32. Woolsey AM, Sunwoo L, Petersen CA et al. Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and vacuole maturation. J Cell Sci 2003; 116(Pt 17):36l 1-3622.
33. Schenkman S, Robbins ES, Nussenzweig V. Attachment of Trypanosoma cruzi to mammalian cells requires parasite energy, and invasion can be independent of the target cell cytoskeleton. Infect Immun 1991; 59(2):645-654.
34. Burleigh BA, Andrews NW. Signaling and host cell invasion by Trypanosoma cruzi. Curr Opin Microbiol 1998; l(4):461-465.
35. DosReis GA, Freirede-Lima CG, Nunes MP et al. The importance of aberrant T-cell responses in Chagas disease. Trends Parasitol 2005; 21(5):237-243.
36. Colli W. Trans-sialidase: A unique enzyme activity discovered in the protozoan Trypanosoma cruzi. FASEB J 1993; 7(13):1257-1264.
37. El-Sayed NM, Myler PJ, Bartholomeu DC et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005; 309(5733):409-4l5.
38. Schenkman S, Eichinger D, Pereira ME et al. Structural and functional properties of Trypanosoma trans-sialidase. Annu Rev Microbiol 1994; 48:499-523.
39. Frasch AC. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitol Today 2000; 16(7):282-286.
40. Cross GA, Takle GB. The surface trans-sialidase family of Trypanosoma cruzi. Annu Rev Microbiol 1993; 47:385-411.
41. Giordano R, Fonts DL, Tewrari D et al. Cloning of a surface membrane glycoprotein specific for the infective form of Trypanosoma cruzi having adhesive properties to laminin. J Biol Chem 1999; 274(6):346l-3468.
42. El-Sayed NM, Myler PJ, Blandin G et al. Comparative genomics of trypanosomatid parasitic protozoa. Science 2005; 309(5733):404-409.
43. Campo V, Di Noia JM, Buscaglia CA et al. Differential accumulation of mutations localized in particular domains of the mucin genes expressed in the vertebrate host stage of Trypanosoma cruzi. Mol Biochem Parasitol 2004; 133(1):81-91.
44. Katzin AM, Colli W. Lectin receptors in Trypanosoma cruzi. An N-acetyl-D-glucosamine-containing surface glycoprotein specific for the trypomastigote stage. Biochim Biophys Acta 1983; 727(2):403-411.
45. Ruiz RC, Favoreto Jr S, Dorta ML et al. Infectivity of Trypanosoma cruzi strains is associated with differential expression of surface glycoproteins with differential Ca2+ signalling activity. Biochem J 1998; 330(Pt 1):505-511.
46. Kahn SJ, Nguyen D, Norsen J et al. Trypanosoma cruzi: Monoclonal antibodies to the surface glycoprotein superfamily differentiate subsets of the 85-kDa surface glycoproteins and confirm simultaneous expression of variant 85-kDa surface glycoproteins. Exp Parasitol 1999; 92(1):48-56.
47. Fonts DL, Ruef BJ, Ridley PT et al. Nucleotide sequence and transcription of a trypomastigote surface antigen gene of Trypanosoma cruzi. Mol Biochem Parasitol 1991; 46(2): 189-200.
48. Franco FR, Paranhos-Bacalla GS, Yamauchi LM et al. Characterization of a cDNA clone encoding the carboxy-terminal domain of a 90-kilodalton surface antigen of Trypanosoma cruzi metacyclic trypomastigotes. Infect Immun 1993; 61 (10):4196-4201.
49. Goncalves MF, Umezawa ES, Katzin AM et al. Trypanosoma cruzi: Shedding of surface antigens as membrane vesicles. Exp Parasitol 1991; 72(1):43-53.
50. Schenkman S, Jiang MS, Hart GW et al. A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells. Cell 1991; 65(7):1117-1125.
51. Schenkman S, Eichinger D. Trypanosoma cruzi trans-siaHdase and cell invasion. Parasitol Today 1993; 9(6):218-222.
52. Tomlinson S, Pontes de Carvalho LC, Vandekerckhove F et al. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. J Immunol 1994; 153(7):3141-3147.
53. Gao W, Wortis HH, Pereira MA. The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of nonspecific Ig secretion. Int Immunol 2002; l4(3):299-308.
54. Ming M, Chuenkova M, Ortega-Barria E et al. Mediation of Trypanosoma cruzi invasion by sialic acid on the host cell and trans-sialidase on the trypanosome. Mol Biochem Parasitol 1993; 59(2):243-252.
55. Todeschini AR, Dias WB, Girard MF et al. Enzymatically inactive trans-sialidase from Trypanosoma cruzi binds sialyl and beta-galactopyranosyl residues in a sequential ordered mechanism. J Biol Chem 2004; 279(7):5323-5328.
56. Ciavaglia Mdo C, de Carvalho TU, de Souza W. Interaction of Trypanosoma cruzi with cells with altered glycosylation patterns. Biochem Biophys Res Commun 1993; 193(2):718-721.
57. Lopez M, Huynh C, Andrade LO et al. Role for sialic acid in the formation of tight lysosome-derived vacuoles during Trypanosoma cruzi invasion. Mol Biochem Parasitol 2002; 119(1):141-145.
58. Hohenester E, Engel J. Domain structure and organisation in extracellular matrix proteins. Matrix Biol 2002; 21(2):115-128.
59. Giordano R, Chammas R, Veiga SS et al. Trypanosoma cruzi binds to laminin in a carbohydrate-independent way. Braz J Med Biol Res 1994; 27(9):2315-2318.
60. Giordano R, Chammas R, Veiga SS et al. An acidic component of the heterogeneous Tc-85 protein family from the surface of Trypanosoma cruzi is a laminin binding glycoprotein. Mol Biochem Parasitol 1994; 65(1):85-94.
61. Ulrich H, Magdesian MH, Alves MJ et al. In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J Biol Chem 2002; 277(23):20756-20762.
62. Marroquin-Quelopana M, Oyama Jr S, Aguiar Pertinhez T et al. Modeling the Trypanosoma cruzi Tc85-ll protein and mapping the laminin-binding site. Biochem Biophys Res Commun 2004; 325(2):612-618.
63. Velge P, Ouaissi MA, Cornette J et al. Identification and isolation of Trypanosoma cruzi trypomastigote collagen-binding proteins: Possible role in cell-parasite interaction. Parasitology 1988; 97(Pt 2):255-268.
64. Calvet CM, Meuser M, Almeida D et al. Trypanosoma cruzi-cardiomyocyte interaction: Role of fibronectin in the recognition process and extracellular matrix expression in vitro and in vivo. Exp Parasitol 2004; 107(1-2):20-30.
65. Herrera EM, Ming M, Ortega-Barria E et al. Mediation of Trypanosoma cruzi invasion by heparan sulfate receptors on host cells and penetrin counter-receptors on the trypanosomes. Mol Biochem Parasitol 1994; 65(1):73-83.
66. Calvet CM, Toma L, De Souza FR et al. Heparan sulfate proteoglycans mediate the invasion of cardiomyocytes by Trypanosoma cruzi. J Eukaryot Microbiol 2003; 50(2):97-103.
67. Ouaissi MA, Cornette J, Capron A. Trypanosoma cruzi: Modulation of parasite-cell interaction by plasma fibronectin. Eur J Immunol 1985; 15(11):1096-1101.
68. Ouaissi MA, Afchain D, Capron A et al. Fibronectin receptors on Trypanosoma cruzi trypomastigptes and their biological function. Nature 1984; 308(5957):380-382.
69. Fernandez MA, Munoz-Fernandez MA, Fresno M. Involvement of beta 1 integrins in the binding and entry of Trypanosoma cruzi into human macrophages. Eur J Immunol 1993; 23(2):552-557.
70. Ouaissi MA. Role of the RGD sequence in parasite adhesion to host cells. Parasitol Today 1988; 4(6): 169-173.
71. Ruoslahti E. The RGD story: A personal account. Matrix Biol 2003; 22(6):459-465.
72. Vray B, Camby I, Vercruysse V et al. Up-regulation of galectin-3 and its ligands by Trypanosoma cruzi infection with modulation of adhesion and migration of murine dendritic cells. Glycobiology 2004; l4(7):647-657.
73. Magdesian MH, Giordano R, Ulrich H et al. Infection by Trypanosoma cruzi. Identification of a parasite ligand and its host cell receptor. J Biol Chem 2001; 276(22): 19382-19389.
74. Masocha W, Robertson B, Rottenberg ME et al. Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrier. J Clin Invest 2004; ll4(5):689-694.
75. Andrade SG, Grimaud JA, Stocker-Guerret S. Sequential changes of the connective matrix components of the myocardium (fibronectin and laminin) and evolution of cardiac fibrosis in mice infected with Trypanosoma cruzi. Am J Trop Med Hyg 1989; 40(3):252-260.
76. Pinho RT, Vannier-Santos MA, Alves CR et al. Effect of Trypanosoma cruzi released antigens binding to noninfected cells on anti-parasite antibody recognition and expression of extracellular matrix components. Acta Trop 2002; 83(2):103-115.
77. Zuniga E, Gruppi A, Hirabayashi J et al. Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages: Modulation of microbicidal activity and survival. Infect Immun 2001; 69(11):6804-6812.
78. Ramirez MI, Ruiz Rde C, Araya JE et al. Involvement of the stage-specific 82-kilodalton adhesion molecule of Trypanosoma cruzi metacyclic trypomastigotes in host cell invasion. Infect Immun 1993; 61(9):3636-3641.
79. Euington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346(6287):818-822.
80. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249(4968):505-510.
81. Ulrich H, Alves MJ, Colli W. RNA and DNA aptamers as potential tools to prevent cell adhesion in disease. Braz J Med Biol Res 2001; 34(3):295-300.
82. Turner CW, Lima MF, Villalta F. Trypanosoma cruzi uses a 45-kDa mucin for adhesion to mammalian cells. Biochem Biophys Res Commun 2002; 290(1):29-34.
83. Marcipar IS, Welchen E, Roodveldt C et al. Purification of the 67-kDa lectin-like glycoprotein of Trypanosoma cruzi, LLGP-67, and its evaluation as a relevant antigen for the diagnosis of human infection. FEMS Microbiol Lett 2003; 220(1):149-154.
84. Scharfstein J, Schmitz V, Morandi V et al. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J Exp Med 2000; 192(9):1289-1300.
85. Ming M, Ewen ME, Pereira ME. Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway. Cell 1995; 82(2):287-296.
86. Aparicio IM, Scharfstein J, Lima AP. A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes. Infect Immun 2004; 72(10):5892-5902.
87. Moro A, Ruiz-Cabello F, Fernandez-Cano A et al. Secretion by Trypanosoma cruzi of a peptidyl-prolyl cis-trans isomerase involved in cell infection. EMBO J 1995; l4(11):2483-2490.
88. Cuevas IC, Cazzulo JJ, Sanchez DO. gp63 homologues in Trypanosoma cruzi: Surface antigens with metalloprotease activity and a possible role in host cell infection. Infect Immun 2003; 71(10):5739-5749.
89. Santana JM, Grellier P, Schrevel J et al. A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV. Biochem J 1997; 325(Pt 1): 129-137.